Advertiser / Brand
Revolution Beauty vs Weleda
Structured technology and market comparison · 2026
Direct Feature Comparison
Revolution Beauty · vs · WeledaPublic beauty brand selling makeup, skincare and haircare products.
Natural cosmetics and anthroposophic medicines brand and retailer.
Analyze all overlapping signals and tech stacks for Revolution Beauty and Weleda
Compare mutual enterprise clients, monetization models, live market signals, and partner networks directly in the interactive Knowledge Graph.
Comparison Analysis
What is the main difference between Revolution Beauty and Weleda?
When comparing Revolution Beauty and Weleda, both platforms operate within the Advertiser / Brand ecosystem. Revolution Beauty is positioned as Public beauty brand selling makeup, skincare and haircare products, whereas Weleda focuses on Natural cosmetics and anthroposophic medicines brand and retailer. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.
What are the top alternatives to Revolution Beauty and Weleda?
When evaluating Revolution Beauty and Weleda, enterprise buyers also consider other platforms in Advertiser / Brand. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.
How do the corporate scale, structure, and headquarters of Revolution Beauty and Weleda compare?
Revolution Beauty is headquartered in GB (founded in 2014) with 201–500 employees. Weleda is based in CH (founded in 1921) with 1,001–5,000 employees. Complete ownership, subsidiary trees, and corporate affiliations are documented across Polaris7.
Market Signals
Recent Market Signals & Activity: Revolution Beauty vs Weleda
Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.
Revolution Beauty
Recent Signals
- ·SEC APIfinancials
8-K Financial Filing Analysis for Revolution Beauty (2026-08-19)
On August 17, 2026, the Compensation Committee of Revelation Biosciences, Inc. approved material restricted stock grants to executive leadership under its Amended and Restated 2021 Equity Incentive Plan. Chief Executive Officer James Rolke received 208,076 restricted shares, and Chief Financial Officer Chester S. Zygmont, III was granted 208,073 restricted shares. The equity awards are structured to vest across four equal 25% tranches linked to either reaching market capitalization hurdles of $30 million, $60 million, $90 million, and $120 million for 20 consecutive trading days, or time-based vesting at the two-year and four-year marks. The package aligns executive compensation with aggressive market valuation targets while providing retention security.
- CEO James Rolke and CFO Chester S. Zygmont, III were granted 208,076 and 208,073 restricted shares, respectively, under the 2021 Equity Incentive Plan.
- Awards vest in four equal 25% tranches upon reaching market capitalization thresholds of $30M, $60M, $90M, and $120M sustained over 20 consecutive trading days, or alternatively at 2-year (first two tranches) and 4-year (final two tranches) time intervals.
- Grants include standard accelerated vesting protections upon a Change in Control or qualified involuntary termination events.
Weleda
Recent Signals
- ·persoenlich.com NewsHiring
Anika Franke Joins Kyte-Tec's Management Team
Kyte-Tec, a MarTech provider for performance-based trade marketing in the German-speaking pharmacy market, has appointed Anika Franke to its management team, effective immediately. Franke, who brings over 20 years of experience in the pharma and pharmacy sector, previously served as Director Sales Pharmacy Germany at Weleda. At Kyte-Tec, she will jointly drive the company's sales strategy with founder Fabian Zink, focusing on key account management and the development of customer and market concepts. The company, founded in 2018 as a digital couponing provider, now positions itself as a leading MarTech provider with the largest network in the German-speaking pharmacy market. Franke expressed excitement about combining technology, data, and AI with deep pharmacy market knowledge to generate tangible sales impact.
- Anika Franke joins Kyte-Tec's management team effective immediately.
- She will co-lead sales strategy with founder Fabian Zink.
- Franke previously was Director Sales Pharmacy Germany at Weleda.
Compare their exact ecosystem overlaps.
Explore all deep relationships in Polaris7. Discover exactly which mutual clients, integrated technologies, and overlapping partners Revolution Beauty and Weleda share across the market ecosystem.
Unlock full capability matrix, client overlaps & technology stacks